Discounting costs and health benefits in cost-effectiveness analysis has been the subject of recent debate -some authors suggesting a common rate for both and others suggesting a lower rate for health. We show how these views turn on key judgments of fact and value: on whether the social objective i
‘Health Economics’ and the evolution of economic evaluation of health technologies
✍ Scribed by John Hutton
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 69 KB
- Volume
- 21
- Category
- Article
- ISSN
- 1057-9230
- DOI
- 10.1002/hec.1818
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Models for the economic evaluation of health technologies provide valuable information to decision makers. The choice of model structure is rarely discussed in published studies and can affect the results produced. Many papers describe good modelling practice, but few describe how to ch
The inclusion of medical costs in life years gained in economic evaluations of health care technologies has long been controversial. Arguments in favour of the inclusion of such costs are gaining support, which shifts the question from whether to how to include these costs. This paper elaborates on
## In an era of constrained health care financing, clinicians are increasingly faced with considering the economic consequences in addition to the clinical outcomes associated with initiating a patient on antidepressant therapy. This has increased the demand for health economic studies comparing ant
The estimation of economic benefits of health effects through direct methods, such as contingent valuation, presents the problem of preference imprecision. This paper deals with this problem by proposing an elicitation method that allows the subject to state an interval for willingness to pay, witho